Noninvasive serum models to predict significant liver related events in chronic hepatitis C.

about

Noninvasive serum models to predict significant liver related events in chronic hepatitis C.

Item

http://www.wikidata.org/entity/Q40151847

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Noninvasive serum models to pr ...... events in chronic hepatitis C.

@en

type

Item

label

Noninvasive serum models to pr ...... events in chronic hepatitis C.

@en

prefLabel

Noninvasive serum models to pr ...... events in chronic hepatitis C.

@en

P1476

Noninvasive serum models to pr ...... events in chronic hepatitis C.

@en

P2093

Benjamin Tharian

http://www.w3.org/2001/XMLSchema#string

Madiha E Soofi

http://www.w3.org/2001/XMLSchema#string

Ragesh Babu Thandassery

http://www.w3.org/2001/XMLSchema#string

Rajvir Singh

http://www.w3.org/2001/XMLSchema#string

Saad Al Kaabi

http://www.w3.org/2001/XMLSchema#string

P2860

Direct anti-HCV agents

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection.

Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring--predictors and predictive models of disease progression

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.

Simple models based on gamma-glutamyl transpeptidase and platelets for predicting survival in hepatitis B-associated hepatocellular carcinoma.

Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay.

Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.

P2888

s12072-017-9800-7

P304

401-408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12072-017-9800-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28634687

http://www.w3.org/2001/XMLSchema#string